Long-Term Results of Hepatic Resection Combined with Intraoperative Local Ablation Therapy for Patients with Multinodular Hepatocellular Carcinomas
Authors:
- 14 October 2009
- journal article
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 16 (12) , 3299-3307
Abstract
Recently, local ablation therapy has been widely used for treatment of small hepatocellular carcinoma (HCC). The present study assessed the outcome of hepatic resection combined with intraoperative local ablation therapy in patients with multinodular HCCs. Forty-one patients with initial and multinodular HCCs underwent hepatic resection combined with intraoperative local ablation therapy. The mean maximum diameter of all tumors was 3.8 cm (range 2.1–16.0 cm), and the mean number of nodules was 3.2 (range 2–11). We evaluated the survival rates and assessed the prognostic factors associated with overall survival rates using Cox proportional hazard models. Intraoperative local ablation therapy was completed in all patients with no evidence of residual viable tumor on the first postoperative computed tomography (CT) scan. The 3-, 5- and 7-year overall survival rates were 84.3%, 61.2%, and 61.2%, respectively. Patients with preoperative des-gamma carboxyprothrombin (DCP) level >300 mAU/ml showed significantly worse overall survival than those with DCP level ≤300 mAU/ml (P < 0.01). Hepatic resection combined with intraoperative local ablation therapy is effective for multinodular HCCs. DCP >300 mAU/ml was a significant prognostic factor of long-term overall survival.Keywords
This publication has 39 references indexed in Scilit:
- Impact of Des-Gamma-Carboxy Prothrombin and Tumor Size on the Recurrence of Hepatocellular Carcinoma After Living Donor Liver TransplantationTransplantation, 2009
- Liver transplantation for hepatocellular carcinomaJournal of Hepato-Biliary-Pancreatic Surgery, 2008
- Longterm Favorable Results of Limited Hepatic Resections for Patients with Hepatocellular Carcinoma: 20 Years of ExperienceJournal of the American College of Surgeons, 2007
- The predictors of microvascular invasion in candidates for liver transplantation with hepatocellular carcinoma—with special reference to the serum levels of des‐gamma‐carboxy prothrombinJournal of Surgical Oncology, 2007
- Long-term outcomes for patients with solitary hepatocellular carcinoma treated by laparoscopic microwave coagulationCancer, 2005
- Local ablation therapy for hepatocellular carcinoma: current status and future perspectivesJournal of Gastroenterology, 2004
- The role of des-γ-carboxy prothrombin levels in hepatocellular carcinoma and liver tissuesCancer Letters, 2000
- Des-γ-carboxy prothrombin and α-fetoprotein positive status as a new prognostic indicator after hepatic resection for hepatocellular carcinomaCancer, 1996
- No treatment, resection and ethanol injection in hepatocellular carcinoma: a retrospective analysis of survival in 391 patients with cirrhosisJournal of Hepatology, 1995
- Lipiodolization for unresectable hepatocellular carcinoma: An analysis of 205 patients using univariate and multivariate analysisJournal of Surgical Oncology, 1994